Array BioPharma Overview

  • Founded
  • 1998

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 298

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $11.4B

  • Investors
  • 3

Array BioPharma General Information

Description

Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its clinical stage drugs include Binimetinib, Encorafenib, Selumetinib, Tucatinib/ONT-380, ARRY-382, LOXO-292 and LOXO-195 among others. The company has geographical presence in North America, Europe and Asia Pacific.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 3200 Walnut Street
  • Boulder, CO 80301
  • United States
+1 (303) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Array BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 30-Jul-2019 $11.4B 00000 000.00 Completed Profitable
8. PIPE 10-Jun-2013 00000 00000 Completed Generating Revenue
7. PIPE 02-May-2011 0000 00000 Completed Generating Revenue
6. Debt - General 19-May-2009 0000 00000 Completed Generating Revenue
5. Debt - General 23-Dec-2008 0000 00000 Completed Generating Revenue
4. IPO 17-Nov-2000 000.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 31-Aug-2000 0000 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Nov-1999 $8M $14.6M 000.00 Completed Startup
1. Early Stage VC (Series A) 15-Jan-1999 $6.6M $6.6M 000.00 Completed Startup
To view Array BioPharma’s complete valuation and funding history, request access »

Array BioPharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00 00 00 00 0.000
Series B 0,000,000 00.0 00.0 00 00.0 00.000
Series A 6,800,000 $1 $1 1x $1 33.62%
To view Array BioPharma’s complete cap table history, request access »

Array BioPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of target
Biotechnology
Boulder, CO
298 As of 2018
00000
00.00 0000-00-00
000000&0 00000

000000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000 000000000
Boston, MA
0 As of 0000
00000
000000000 00000

000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000 000000000
Alameda, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Array BioPharma Competitors (55)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aileron Therapeutics Formerly VC-backed Boston, MA 0 00000 000000000 00000
00000000 Formerly VC-backed Alameda, CA 000 00000 000000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000-000 0000000 Venture Capital-Backed Palo Alto, CA 00 00000 0000000000 00000
You’re viewing 5 of 55 competitors. Get the full list »

Array BioPharma Patents

Array BioPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200407344-A1 Compounds for the treatment of braf-associated diseases and disorders Pending 28-Jun-2019 0000000000
US-20200317665-A1 Protein tyrosine phosphatase inhibitors Pending 02-Apr-2019 00000000000
AU-2020251841-A1 Protein tyrosine phosphatase inhibitors Pending 02-Apr-2019 00000000000
CA-3135555-A1 Protein tyrosine phosphatase inhibitors Pending 02-Apr-2019 00000000000
AU-2020205035-A1 Quinoline compounds as inhibitors of tam and met kinases Pending 03-Jan-2019 C07D401/14
To view Array BioPharma’s complete patent history, request access »

Array BioPharma Executive Team (41)

Name Title Board Seat Contact Info
Ron Squarer Chief Executive Officer
Nicholas Saccomano Ph.D Chief Scientific Officer
Michael Needle MD Chief Medical Officer
You’re viewing 3 of 41 executive team members. Get the full list »

Array BioPharma Board Members (13)

Name Representing Role Since
Liam Ratcliffe Ph.D Self Board Member 000 0000
You’re viewing 1 of 13 board members. Get the full list »

Array BioPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Array BioPharma Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Boulder Ventures Venture Capital Minority 000 0000 000000 0
Falcon Technology Partners Venture Capital Minority 000 0000 000000 0
Frazier Healthcare Partners PE/Buyout Minority 000 0000 000000 0
Mosaix Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Array BioPharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 02-Mar-2015 000000000 Buildings and Property
Loxo Oncology Early Stage VC Pharmaceuticals
To view Array BioPharma’s complete investments history, request access »

Array BioPharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000000 00000 00000 00 Completed
  • 2 buyers
To view Array BioPharma’s complete exits history, request access »